isscr_guidelinesbanner_1280x200_01
ISSCR AM21 WebBanner

©2021 by The International Society for Stem Cell Research. All rights reserved.

No part of this document may be produced in any form without written permission of The International Society for Stem Cell Research.

3.6 Clinical Application

Clinical translation continues after a product is taken into clinical practice. Realizing the full potential of a product requires gathering additional safety and efficacy evidence, controlling applications that lack complete evidentiary footing, and pricing products in a way that delivers value for patients and healthcare systems.

previous

~/policy/guidelines-for-stem-cell-research-and-clinical-translation/sections/part3/part31

sideways

Next

~/policy/guidelines-for-stem-cell-research-and-clinical-translation/sections/part3/part36/part361

move up